Articles citing this paper
Virological significance, prevalence and genetic basis of hypersusceptibility to nonnucleoside reverse transcriptase inhibitors
Gilda Tachedjian A B C E and Anne Mijch D
+ Author Affiliations
- Author Affiliations
A Molecular Interactions Group, Macfarlane Burnet Institute for Medical Research and Public Health, GPO Box 2284, Melbourne, Vic. 3001, Australia.
B Department of Microbiology, Monash University, Clayton, Vic. 3800, Australia.
C Department of Medicine, Monash University, Prahran, Vic. 3181, Australia.
D Victorian HIV Service, Department of Infectious Diseases and Microbiology, Alfred Hospital, Prahran, Vic. 3181, Australia.
E Author for correspondence; email: gildat@burnet.edu.au
Sexual Health 1(2) 81-89 https://doi.org/10.1071/SH03012
Submitted: 15 October 2003 Accepted: 5 April 2004 Published: 24 June 2004
4 articles found in Crossref database.
Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)
de Béthune Marie-Pierre
Antiviral Research. 2010 85(1). p.75
Biophysical Characterization of p51 and p66 Monomers of HIV-1 Reverse Transcriptase with Their Inhibitors
Seetaha Supaphorn,
Kamonsutthipaijit Nuntaporn,
Yagi-Utsumi Maho,
Seako Yanaka,
Yamaguchi Takumi,
Hannongbua Supa,
Kato Koichi, Choowongkomon Kiattawee
The Protein Journal. 2023 42(6). p.741
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA
Bannister Wendy P,
Ruiz Lidia,
Cozzi-Lepri Alessandro,
Mocroft Amanda,
Kirk Ole,
Staszewski Schlomo,
Loveday Clive,
Karlsson Anders,
Monforte Antonella d'Arminio,
Clotet Bonaventura, Lundgren Jens D
AIDS. 2008 22(3). p.367
Antiviral Activity of MK-4965, a Novel Nonnucleoside Reverse Transcriptase Inhibitor
Lai Ming-Tain,
Munshi Vandna,
Touch Sinoeun,
Tynebor Robert M.,
Tucker Thomas J.,
McKenna Philip M.,
Williams Theresa M.,
DiStefano Daniel J.,
Hazuda Daria J., Miller Michael D.
Antimicrobial Agents and Chemotherapy. 2009 53(6). p.2424
